Tech Company M&A Transactions
BioLucent Acquisition
Operating out of Aliso Viejo, BioLucent was bought by Hologic. Purchase price was estimated to be $70 million.
Transaction Overview
Company Name
Acquired By
Announced On
6/22/2007
Transaction Type
M&A
Amount
$70,000,000
M&A Terms
The price includes $5 million in cash and $65 million in cash, shares of Hologic, or a combination of both. The earn out would be payable in two annual cash installments not to exceed $15 million.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
6 Journey 325
Aliso Viejo, CA 92656
USA
Aliso Viejo, CA 92656
USA
Phone
Website
Email Address
Overview
BioLucent is a women's health company focused on the early detection and treatment of breast cancer. Our products remove a major barrier to screening mammography and offer innovative solutions to treat early breast cancers. We design, manufacture and supply medical devices that reinvent the patient experience and improve quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Gex
Browse more venture capital transactions:
Prev: 6/22/2007: Adventenna venture capital transaction
Next: 6/24/2007: Tempo Payments venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs